Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
30 11 2022
Historique:
entrez: 19 12 2022
pubmed: 20 12 2022
medline: 21 12 2022
Statut: epublish

Résumé

Biobanks are key research infrastructures aimed at the collection, storage, processing, and sharing of high-quality human biological samples and associated data for research, diagnosis, and personalized medicine. The Biobank for Translational and Digital Medicine Unit at the European Institute of Oncology (IEO) is a landmark in this field. Biobanks collaborate with clinical divisions, internal and external research groups, and industry, supporting patients' treatment and scientific progress, including innovative diagnostics, biomarker discovery, and clinical trial design. Given the central role of biobanks in modern research, biobanking standard operating procedures (SOPs) should be extremely precise. SOPs and controls by certified specialists ensure the highest quality of samples for the implementation of science-based, diagnostic, prognostic, and therapeutic personalized strategies. However, despite numerous efforts to standardize and harmonize biobanks, these protocols, which follow a strict set of rules, quality controls, and guidelines based on ethical and legal principles, are not easily accessible. This paper presents the biobank standard operating procedures of a large cancer center.

Identifiants

pubmed: 36533819
doi: 10.3791/63950
doi:

Types de publication

Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Giuseppina Bonizzi (G)

Biobank for Translational and Digital Medicine Unit, IEO, European Institute of Oncology IRCCS.

Maria Capra (M)

Biobank for Translational and Digital Medicine Unit, IEO, European Institute of Oncology IRCCS.

Cristina Cassi (C)

Biobank for Translational and Digital Medicine Unit, IEO, European Institute of Oncology IRCCS.

Giulio Taliento (G)

Biobank for Translational and Digital Medicine Unit, IEO, European Institute of Oncology IRCCS.

Oriana Pala (O)

Division of Pathology, IEO, European Institute of Oncology IRCCS.

Elham Sajjadi (E)

Division of Pathology, IEO, European Institute of Oncology IRCCS; Department of Oncology and Hemato-Oncology, University of Milan.

Konstantinos Venetis (K)

Division of Pathology, IEO, European Institute of Oncology IRCCS; Department of Oncology and Hemato-Oncology, University of Milan.

Mariia Ivanova (M)

Division of Pathology, IEO, European Institute of Oncology IRCCS.

Massimo Monturano (M)

Patient Safety & Risk Management Service, IEO, European Institute of Oncology IRCCS.

Giuseppe Renne (G)

Division of Pathology, IEO, European Institute of Oncology IRCCS.

Lorenzo Zattoni (L)

Biobank for Translational and Digital Medicine Unit, IEO, European Institute of Oncology IRCCS; Department of Oncology and Hemato-Oncology, University of Milan.

Elena Guerini-Rocco (E)

Division of Pathology, IEO, European Institute of Oncology IRCCS; Department of Oncology and Hemato-Oncology, University of Milan.

Giuseppe Viale (G)

Division of Pathology, IEO, European Institute of Oncology IRCCS; Department of Oncology and Hemato-Oncology, University of Milan.

Roberto Orecchia (R)

Scientific Directorate, IEO, European Institute of Oncology IRCCS.

Nicola Fusco (N)

Biobank for Translational and Digital Medicine Unit, IEO, European Institute of Oncology IRCCS; Division of Pathology, IEO, European Institute of Oncology IRCCS; Department of Oncology and Hemato-Oncology, University of Milan; nicola.fusco@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH